A Study to Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization Schedule
Clinical trial NCT03566940 · COMPLETED
Trial details
- NCT number
- NCT03566940
- Sponsor
- Janssen Vaccines & Prevention B.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-31
- Primary completion
- 2019-08-07
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.